BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38847538)

  • 21. A method to quantify viable carbapenem resistant gram-negative bacteria in treated and untreated wastewater.
    Reinke RA; Quach-Cu J; Allison N; Lynch B; Crisostomo C; Padilla M
    J Microbiol Methods; 2020 Dec; 179():106070. PubMed ID: 33017624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes of intestinal transplant recipients colonized with multidrug-resistant organisms: a retrospective study.
    Simkins J; Morris MI; Camargo JF; Vianna R; Beduschi T; Abbo LM
    Transpl Int; 2017 Sep; 30(9):924-931. PubMed ID: 28544183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide identification of carbapenem-resistant Gram-negative bacterial (CR-GNB) isolates retrieved from hospitalized patients in Bihar, India.
    Kumari N; Kumar M; Katiyar A; Kumar A; Priya P; Kumar B; Biswas NR; Kaur P
    Sci Rep; 2022 May; 12(1):8477. PubMed ID: 35590022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active Screening of Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae for Subsequent Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplantation.
    Cao W; Zhang J; Bian Z; Li L; Zhang S; Qin Y; Wan D; Jiang Z; Zhang R
    Infect Drug Resist; 2022; 15():5993-6006. PubMed ID: 36262593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
    PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and risk factors for acquired colonization and infection due to extended-spectrum beta-lactamase-producing Gram-negative bacilli: a retrospective analysis in three ICUs with low multidrug resistance rate.
    Massart N; Camus C; Benezit F; Moriconi M; Fillatre P; Le Tulzo Y
    Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):889-895. PubMed ID: 31898797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance culture for multidrug-resistant gram-negative bacteria: Performance in liver transplant recipients.
    Freire MP; Villela Soares Oshiro IC; Bonazzi PR; Pierrotti LC; de Oliveira LM; Machado AS; Van Der Heijdenn IM; Rossi F; Costa SF; Carneiro D'Albuquerque LA; Abdala E
    Am J Infect Control; 2017 Mar; 45(3):e40-e44. PubMed ID: 28254253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Risk Factors and Microbiological and Intestinal Characteristics of Carbapenemase-Producing
    Yuan W; Xu J; Guo L; Chen Y; Gu J; Zhang H; Yang C; Yang Q; Deng S; Zhang L; Deng Q; Wang Z; Ling B; Deng D
    Microbiol Spectr; 2022 Dec; 10(6):e0190621. PubMed ID: 36445086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colonization With Antimicrobial-Resistant Gram-Negative Bacilli at Neonatal Intensive Care Unit Discharge.
    Clock SA; Ferng YH; Tabibi S; Alba L; Patel SJ; Jia H; DeLaMora P; Perlman JM; Paul DA; Zaoutis T; Larson EL; Saiman L
    J Pediatric Infect Dis Soc; 2017 Sep; 6(3):219-226. PubMed ID: 27021036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and factors associated with carbapenem-resistant Enterobacterales (CRE) infection among hematological malignancies patients with CRE intestinal colonization.
    Chen X; Wen X; Jiang Z; Yan Q
    Ann Clin Microbiol Antimicrob; 2023 Jan; 22(1):3. PubMed ID: 36627626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Modifying Empirical Antibiotic Therapy Based on Intestinal Colonization Status on Clinical Outcomes of Febrile Neutropenic Patients.
    Alrstom A; Alsuliman T; Daher N; Abouharb R
    Infect Chemother; 2021 Mar; 53(1):63-74. PubMed ID: 33538132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients.
    Armand-Lefèvre L; Angebault C; Barbier F; Hamelet E; Defrance G; Ruppé E; Bronchard R; Lepeule R; Lucet JC; El Mniai A; Wolff M; Montravers P; Plésiat P; Andremont A
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1488-95. PubMed ID: 23318796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemases.
    Álvarez-Marín R; López-Cerero L; Guerrero-Sánchez F; Palop-Borras B; Rojo-Martín MD; Ruiz-Sancho A; Herrero-Rodríguez C; García MV; Lazo-Torres AM; López I; Martín-Hita L; Nuño-Álvarez E; Sánchez-Yebra W; Galán-Sánchez F; Reguera-Iglesias JM; Lepe JA; Peñalva G; Pascual Á; Cisneros JM;
    J Antimicrob Chemother; 2021 Jun; 76(7):1928-1936. PubMed ID: 33769481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and risk factors of carbapenem-resistant
    Guo B; Guo Z; Zhang H; Shi C; Qin B; Wang S; Chang Y; Chen J; Chen P; Guo L; Guo W; Han H; Han L; Hu Y; Jin X; Li Y; Liu H; Lou P; Lu Y; Ma P; Shan Y; Sun Y; Zhang W; Zheng X; Shao H
    Front Microbiol; 2022; 13():894341. PubMed ID: 36187994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbapenem-Resistant Gram-Negative Bacilli Characterization in a Tertiary Care Center from El Bajio, Mexico.
    Nieto-Saucedo JR; López-Jacome LE; Franco-Cendejas R; Colín-Castro CA; Hernández-Duran M; Rivera-Garay LR; Zamarripa-Martinez KS; Mosqueda-Gómez JL
    Antibiotics (Basel); 2023 Aug; 12(8):. PubMed ID: 37627715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of and risk factors for intestinal colonisation by multidrug-resistant Gram-negative bacteria in patients with haematological malignancies: A systematic review and meta-analysis.
    Luo H; Chen X; Jiang Z; Yan Q
    Int J Antimicrob Agents; 2024 Jan; 63(1):107043. PubMed ID: 38040318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquisition of carbapenem-resistant Gram-negative bacilli in intensive care unit: predictors and molecular epidemiology.
    Marchenay P; Blasco G; Navellou JC; Leroy J; Cholley P; Talon D; Bertrand X; Gbaguidi-Haore H
    Med Mal Infect; 2015; 45(1-2):34-40. PubMed ID: 25640914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology, drug resistance analysis and mortality risk factor prediction of gram-negative bacteria infections in patients with allogeneic hematopoietic stem cell transplantation.
    Liu Y; Liu Y; Liu Y; Chen X; Jia Y
    Heliyon; 2023 Apr; 9(4):e15285. PubMed ID: 37101646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for nosocomial rectal colonisation with carbapenem-resistant Gram-negative bacilli in children with haematological malignancies: a case-control study.
    Fang C; Zhou Z; Zhou M; Li J
    Ann Clin Microbiol Antimicrob; 2023 Aug; 22(1):66. PubMed ID: 37537568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
    Lima EM; Cid PA; Beck DS; Pinheiro LHZ; Tonhá JPS; Alves MZO; Lourenço ND; Santos RQ; Asensi MD; Marques JA; Bandeira CS; Rodrigues CAS; Gomes Junior SCS; Gomes MZR;
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):132. PubMed ID: 32795380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.